Alan Sandler (Roche via YouTube)
A top cancer R&D exec at Genentech joins the exodus, jumping to a marquee China biotech as the new oncology chief, dealmaker
In the oncology world, there’s no better hunting ground for cancer R&D execs than Genentech. The biotech franchise at Roche has worked on some of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
